Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001425738-12-000004
Filing Date
2012-04-06
Accepted
2012-04-05 17:35:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 cyclacel_13g.htm SC 13G 44065
  Complete submission text file 0001425738-12-000004.txt   45669
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80136 | Film No.: 12746632
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 PINE STREET, SUITE 1925 SAN FRANCISCO CA 94111
Business Address 100 PINE STREET, SUITE 1925 SAN FRANCISCO CA 94111 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

EIN.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G